Coalition for Epidemic Preparedness Innovations (CEPI), Uppsala, Sweden 

Rebecca Chandler, a native of the US, was educated and trained as a physician in both internal medicine and infectious diseases. Her career took an unexpected turn into vaccine safety in 2008 when she started work as a clinical safety assessor at the Swedish Medical Products Agency. She was involved in the assessment of pre- and post-authorisation safety data of many of the vaccines used in national immunization programmes today, including two pneumococcal vaccines, the first meningococcal B vaccine, and the HPV vaccines. She was forever changed by the Pandemirix-narcolepsy vaccine safety crisis during the H1N1 pandemic when her professional aspirations in vaccine safety became solidified. She moved to the Uppsala Monitoring Centre, the WHO Collaborating Centre for International Drug Monitoring, in 2014 and there she was involved in the evaluation of new methodologies for mining the global database of suspected adverse drug reactions and in capacity building efforts in signal detection in pharmacovigilance around the globe. She moved to Coalition for Epidemic Preparedness Innovations (CEPI) in 2021 to build a concept of vaccine safety and pharmacovigilance into CEPI’s a mission for a response to public health emergencies in 100 days.

Rebecca Chandler teaches "Vaccine safety and pharmacovigilance" on Tuesday 17 June 2025.